Upload Avatar (500 x 500)
Jianjun Ge
zkdgjj@ustc.edu.cn
Chinese, English, German, Japanese
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 1993-1998: PhD in Surgery (Cardiothoracic Surgery) from China Medical University
  • 1985-1990: Bachelor's degree in Clinical Medicine from Anhui Medical University
  • 2016.12-present: Chief Physician, Professor, Doctoral Supervisor, Department Director at the First Affiliated Hospital of USTC
  • 2006.11-2016.11: Professor, Chief Physician, Doctoral Supervisor, Cardiovascular Surgery Director, Party Branch Secretary at the First Affiliated Hospital of Anhui Medical University
  • 2012.12-2013.03: Clinical Training at Cleveland Heart Center, USA
  • 2008.11-2009.03: Clinical Training at Karlsruhe Heart Surgery Hospital, Germany
  • 2005.11-2006.09: Chief Physician, Associate Professor, Master's Supervisor, Deputy Director of Foreign Experts Teaching and Research Office at the First Affiliated Hospital of Anhui Medical University
  • 2003.11-2004.02: Clinical Training at Nagoya University School of Medicine, Japan
  • 2000.09-2005.11: Associate Chief Physician, Associate Professor, Master's Supervisor, Deputy Director of Foreign Experts Teaching and Research Office at the First Affiliated Hospital of Anhui Medical University
  • 1998.08-2000.09: Attending Physician at the Department of Cardiothoracic Surgery, First Affiliated Hospital of Anhui Medical University
  • 1996.05-1997.05: Studied at Kyushu University School of Medicine, Japan (Joint PhD Program)
  • 1990.09-1993.07: Resident Physician at the Department of Cardiothoracic Surgery, First Affiliated Hospital of Anhui Medical University
Prevention and treatment of vein graft restenosis after coronary artery bypass surgery
NO treatment for pulmonary hypertension
Artificial kidney materials
  • Bletilla striata Polysaccharide Prevents Restenosis of Vein Graft Through Inhibiting Cell Proliferation in Rat Model, Dai Chun, Zhou Yang, Zhang Bing, Jianjun Ge, 2020
  • CD4+ T cells and TGFβ1/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease, Zhao Zhiwei, He Danqing, Ling Fei, Chu Tianshu, Huang Dake, Wu Huaxun, Jianjun Ge, 2020
  • Adenosine A2a receptor agonist CGS21680 treatment attenuates cardiopulmonary bypass-associated inflammatory lung injury in juvenile rats, Kong Xiang, Zuo Yi, Huang Yuang, Jianjun Ge, 2020
  • Prior reconstruction of an isolated left vertebral artery for Stanford type A aortic dissection, Zuo Yi, Zhou Zhengchun, Jianjun Ge, 2021
  • A novel UV-curable extravascular stent to prevent restenosis of venous grafts, Dai Chun, Chu Tianshu, Li Xiang, Jiang Hui, Liu Tan, Zhou Yang, Gao Lei, Shen Cheng, Jianjun Ge, 2021
  • Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis, Jiang Hui, Zhou Yongwen, Seyed Nabavi, Amirhossein Sahebkar, Peter Little, Xu Suowen, Weng Jianping, Jianjun Ge, 2022
  • Pentoxifylline Prevents Restenosis by Inhibiting Cell Proliferation via p38MAPK Pathway in Rat Vein Graft Model, Fan Yangming, Jianjun Ge, 2022
  • A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts, Chu Tianshu, Li Qingye, Dai Chun, Li Xiang, Kong Xiang, Fan Yangming, Yin Hongyan, Jianjun Ge, 2023
Coronary Artery Bypass Vein Graft Restenosis Prevention Treatment Pulmonary Hypertension No Therapy Artificial Kidney Materials Cardiovascular

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.